(Q37380110)

20 August 2017

title

Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005). (English)

1 reference

20 August 2017

main subject

squamous cell carcinoma

1 reference

V L Gill

1

1 reference

20 August 2017

P J Bergman

2

1 reference

20 August 2017

K E Baer

3

1 reference

20 August 2017

D Craft

4

1 reference

20 August 2017

C Leung

5

1 reference

20 August 2017

language of work or name

1 reference

1 March 2008

1 reference

Veterinary and Comparative Oncology

20 August 2017

published in

1 reference

20 August 2017

volume

6

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

55-64

1 reference

Guidelines for management of Bowen's disease. British Association of Dermatologists

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Guidelines for management of Bowen's disease: 2006 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Human papillomavirus and extragenital in situ carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

A review of imiquimod 5% cream for the treatment of various dermatological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Imiquimod 5% cream in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Imiquimod as a dermatological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Feline papillomas and papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

Detection of novel papillomaviruslike sequences in paraffin-embedded specimens of invasive and in situ squamous cell carcinomas from cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2007.00144.X

10.1111/J.1476-5829.2007.00144.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference